Risk factors

Xeris Biopharma Holdings (XERS) risk factors

Item 1A of every Xeris Biopharma Holdings, Inc. 10-K on file, and what changed from one year to the next.

Open XERS in Gloomberb →
  • FY2025 10-K risk factors

    74 risks, 4 new, 4 dropped, 16 reworded since the prior year. Xeris added new disclosures addressing U.S. most-favored-nation drug pricing executive orders, CMS Medicaid payment initiatives, artificial intelligence risks, and social media compliance.

    Filed Mar 02, 2026
  • FY2024 10-K risk factors

    74 risks. Xeris Biopharma faces concentrated customer risk with four accounts generating over ninety percent of gross product revenue.

    Filed Mar 06, 2025